Back to search
Rotavirus
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rotavirus trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rotavirus trials you may qualify forRACSMEI addresses the high burden of infectious diseases in low- and middle-income countries, including Cambodia, where limited surveillance and laboratory capa…
The Phase II clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in infants aged 6 to 12 weeks. T…
Background: China's healthcare system for children faces significant challenges, particularly due to the limited pediatric service capacity of primary healthcar…
The Phase I clinical trial of the oral hexavalent reassortant rotavirus attenuated live vaccine (Vero Cells) will be conducted in a population ranging from 6 we…
This is a study of CDC-9 inactivated rotavirus vaccine (IRV) microneedle patch (MNP) for intradermal administration in healthy adults aged 18 to 45 years at two…